Dr. Mark Lamet, MD

Dr. Lamet practices at The Center for Gastrointestinal Disorders in Hollywood, Florida.

Dr. Lamet's NPI, 1972554731, was assigned on May 15, 2006. Dr. Lamet graduated from Renaissance School of Medicine at Stony Brook University in 1979. Dr. Lamet holds Florida license ME0037518.

Dr. Lamet's primary practice is The Center for Gastrointestinal Disorders, at 3800 Johnson St, Hollywood, FL 33021 in Broward County. The practice phone is (954) 961-7771.

Dr. Lamet's primary practice is The Center for Gastrointestinal Disorders in Hollywood, Florida. Dr. Lamet is also affiliated with Memorial Regional Hospital. The medical group on file is The Center for Gastrointestinal Disorders. Dmand AI also links Dr. Lamet to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lamet practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lamet's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lamet is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Lamet's licenses on file in 9 states: Florida, Montana, North Dakota, Iowa, Wisconsin, West Virginia, South Carolina, Ohio and Colorado.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids and hepatitis c among the conditions Dr. Lamet treats.

CMS data shows 363 Medicare services from Dr. Lamet across 6 procedure codes in 2024, for 197 Medicare patients. Medicare paid $32,645 for them.

CMS counts 197 Medicare patients who saw Dr. Lamet in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lamet's median patient age at 62, with 53% women.

In 2024, Dr. Lamet wrote 2,082 Medicare Part D claims for 970 patients. 75% of them were for generic drugs. CMS names the drug for 1,866 of them, across 24 drugs with 11 or more claims each, at $179,574 in total drug cost. In 2023, CMS named 1,436 claims across 20 drugs.

Dr. Lamet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of colonoscopy by Dr. Lamet, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Lamet in 2017. Dr. Lamet has published most often in Am J Gastroenterol. Dr. Lamet's most frequent co-authors are Abhishek Agnihotri, MD, Christopher R. Bartalos, DO and Dayna S. Early, MD.

Dmand AI links Dr. Lamet to 8 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Abdominal Pain, Colitis, Ulcerative and Crohn Disease. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Lamet that name 9 trials.

CMS Open Payments shows 466 general payments to Dr. Lamet from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Allergan Inc. paid the most, $8,911. It also lists 105 research payments totaling $87,929 from 2016 to 2024, naming 9 clinical trials.

Dmand AI lists 1 award for Dr. Lamet.

Dr. Lamet graduated from Renaissance School of Medicine at Stony Brook University in 1979. Dr. Lamet is a member of ACG.

Dr. Lamet is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.